| Sanwa Kagaku Kenkyusho Co., Ltd Patent applications |
| Patent application number | Title | Published |
|---|
| 20120101137 | NOVEL THIOPHENECARBOXAMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF - The object of the present invention is to provide a compound having a glucokinase-activating effect. | 04-26-2012 |
| 20110071166 | MEDICINE CONSISTING OF CONCOMITANT USE OR COMBINATION OF DPP-IV INHIBITOR AND OTHER DIABETIC MEDICINE - The problem to be solved by the present invention is to provide a medicine which is excellent in the treatment of type 2 diabetes, diabetic complications or impaired glucose tolerance. The present invention provides a medicine characterized in that a compound represented by the following general formula (I), a salt thereof, or a solvate thereof, and at least one kind of other diabetic medicine: | 03-24-2011 |
| 20100305177 | PROPHYLACTIC OR THERAPEUTIC AGENT FOR DIABETIC MACULOPATHY - A prophylactic or therapeutic agent for diabeticmaculopathy, which can be administered for a long time and exhibits efficacy in a mechanism different from that of existing medicines. The invention relates to a prophylactic or therapeutic agent for diabetic maculopathy, comprising, as an active ingredient, a compound represented by the general formula: | 12-02-2010 |
| 20100216856 | PROTECTIVE AGENT FOR RETINAL NERVE OR OPTIC NERVE - The present invention provides a protective agent for retinal nerve or optic nerve which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for long periods. The present invention is the protective agent for retinal nerve or optic nerve which comprises a compound with aldose reductase inhibiting activity such as the compound represented by the following general formula as an active ingredient. A preferable compound thereof is (2S,4S)-6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide: | 08-26-2010 |
| 20090176841 | NOVEL 6-5 SYSTEM BICYCLIC HETEROCYCLIC DERIVATIVE AND ITS PHARMACEUTICAL UTILITY - An object of the present invention is to provide a medicament as a thyroid hormone receptor ligand which is sufficient in drug efficacy and safety, and has the excellent action as a drug. The present invention provides a compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof: | 07-09-2009 |
| 20090076105 | PREVENTIVE OR THERAPEUTIC AGENT FOR CEREBRAL ISCHEMIC INJURY OR CEREBRAL ISCHEMIA REPERFUSION IN STROKE - The present invention provides a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke such as cerebral infarction and cerebral hemorrhage which exerts its effect through a different mechanism from that of conventional therapeutic agents and can be taken for along period. The present invention is a preventive or therapeutic agent for cerebral ischemic injury or cerebral ischemic reperfusion injury in stroke which contains 6-fluoro-2′,5′-dioxospiro[chroman-4,4′-imidazolidine]-2-carboxamide as an active ingredient. A particularly preferable compound is an optically resolved (2S,4S)-form of fidarestat. | 03-19-2009 |
| 20080255217 | PREVENTIVE OR THERAPEUTIC AGENT FOR CARDIAC DYSFUNCTION OR MYOCARDIAL INJURY CAUSED BY ISCHEMIA OR ISCHEMIA REPERFUSION - Disclosed herein is at least a method of preventing or treating cardiac dysfunction or myocardial injury caused by ischemia or ischemia reperfusion | 10-16-2008 |
